“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

The fear of expectation and the unknown may often lead patients to refuse screenings or tests. It’s your job to try and help ...

Leaders from the world of reimbursement explored the complex relationship between payers and providers in oncology, focusing ...

In this free webinar, learn about the advantages of leveraging EPQT and AI-powered data quality in early phase QT assessment. The featured speakers will share considerations for determining whether ...

Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...

Multidisciplinary rounds boost care team communication, which improves clinical outcomes, bolsters patient experience, and reduces medical errors, this new CMO says.

JAMA editors' list of top research for 2025 includes studies on GLP-1 drugs and heart failure, the shingles vaccine and ...

Rushing Headlong: Health IT's Legacy and the Road to Responsible AI by Dr. S. Yin Ho is an indispensable book about the current state of health information technology and how responsible AI could ...

The risk-based screening strategy was associated with similar detection rates for any cancer compared with annual screening ...

In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting advanced cancers but did not reduce breast biopsy rates.

Debra Patt, MD, PhD, MBA, MPH, spoke at SABCS about the importance of patient-investigator collaboration to enhance the clinical trial process.

Nadunolimab combined with chemotherapy showed no significant efficacy improvement in metastatic TNBC, despite surpassing ...